Metabolic Therapy Case report – 56-Year-Old Woman with Chronic Lymphocytic Leukemia (CLL) Maintains Stable Disease for Over 15 Years Without Chemotherapy!
https://pmc.ncbi.nlm.nih.gov/articles/PMC6380985 STORY: In 2001, a 56-year-old woman was diagnosed with Chronic Lymphocytic Leukemia (CLL) during a routine check-up. Her white blood cell (WBC) count was 53.7 x 10⁹/L, but she had no symptoms. She was classified as Rai stage II and Binet stage A, meaning her disease was at an early stage but had the potential to progress. She declined conventional chemotherapy […]
Spike Protein Detox in a Breast Cancer Patient: A Case Report
Spike Protein Detox in a Breast Cancer Patient: A Case Report A targeted intervention that took spike IgG from ~100 to undetectable — and why this matters for every cancer patient with prior COVID exposure or vaccination. Why I’m Writing This In oncology, we focus on the tumor. We measure it, image it, target it. […]
TARGETED METABOLIC CANCER THERAPY CASE REPORT: Borderline High-Risk Prostate Cancer Shows Rapid PSA Reduction (–46%), Near-Complete Inflammation Resolution (–99%), and Hormonal Rebalancing Within 1 Month
Patient profile Age: 65 yearsSex: Male Clinical History Diagnosis (2025) BLOOD MARKER EVOLUTION (29 Dec 2025 → 30 Jan 2026) Marker Before After Interpretation PSA (ng/mL) 5.7 3.1 –46% CRP (mg/L) 62 0.8 –99% CEA 1.43 0.96 Reduced RBC 4.88 4.98 Stable WBC 8.91 7.9 Normalized Hemoglobin (g/dL) 13.9 13.9 Stable Lymphocytes (abs) 4.12 4.32 Strong immune […]
TARGETED METABOLIC CANCER THERAPY CASE REPORT: Stage IV Pancreatic Cancer With Liver Metastases Achieves No Evidence of Disease (NED) After 14 Months of Combined Immunotherapy and Metabolic Intervention
BACKGROUND Patient: 59-year-old maleCancer Type: Pancreatic adenocarcinomaStage at Diagnosis: Stage IVMetastatic Site: LiverTime Since Diagnosis: ~14 months Pancreatic cancer is among the most aggressive solid tumors, with poor outcomes once metastatic. This case is notable for early metabolic intervention combined with immunotherapy, resulting in sustained disease control. TUMOR & DISEASE CHARACTERISTICS CURRENT CANCER STATUS Overall […]
TARGETED METABOLIC CANCER THERAPY CASE REPORT: Metastatic Poorly Differentiated NSCLC Shows ~80% Reduction in Tumor Activity Markers and Complete Inflammation Reversal Over 4 Months
BACKGROUND Diagnosis: Metastatic poorly differentiated non-small cell lung adenocarcinoma (NSCLC)Primary tumor: Right lower lobeStage: Advanced metastatic disease Documented Metastatic Spread (PET-CT, 23 April 2025) This represents a high-burden, poorly differentiated metastatic lung cancer, typically associated with rapid progression, severe inflammation, high LDH, anemia, bone involvement, and hypercoagulability. The patient has been following Targeted Metabolic Therapy […]
TARGETED METABOLIC CANCER THERAPY CASE REPORT (Ivermectin, Fenbendazole, CDS, Ketogenic diet & more…), 34% reduction in PSA in 4 weeks.
64-Year-Old Male With Metastatic Prostate Cancer, Lung Masses & Liver Lesions — Baseline Status and 4-Week Metabolic Response BACKGROUND PET/CT imaging confirmed aggressive, multi-system metastatic disease: Despite no local recurrence in the prostate bed, the cancer is clearly progressing systemically. Baseline PSA: 43.8 ng/mL BASELINE METABOLIC STATUS (Before protocol) Marker Before Interpretation Fasting Glucose 107.4 […]
Case Report Study: Glioblastoma (2016 → 2023+), Complete & durable remission without ongoing chemo, 7+ years stable, patient alive and well
The Patient 36-year-old female — GBM (IDH-wt, MGMT methylated, Ki-67 70%)• 21 Aug 2016: CT — two large left fronto-parietal masses• 24 Aug 2016: Partial resection; poor prognosis• 12 Oct 2016: Residual 2 cm enhancing nodule• Oct–Nov 2016: RT 59.4 Gy/33 fx + 1 cycle TMZ (120 mg x5d) → stopped for thrombocytopenia/side effects• Nov […]
CDS & Metabolic Therapy case report– 58-Year-Old Woman with Uterine Sarcoma & Carcinomatous Meningitis Achieves Full Remission After Refusing Palliative Chemotherapy
STORY:A 58-year-old French woman was diagnosed in February 2015 with undifferentiated uterine sarcoma with lung metastasis. She initially responded to chemotherapy (Ifosfamide, Adriamycin, Cisplatin) and later to Trabectedin + radiotherapy, achieving a temporary complete response. However, in September 2016, she experienced cerebral hypertension and intense pain. MRI revealed carcinomatous meningitis, and tumor cells were found in the cerebrospinal fluid. She was offered palliative chemotherapy, which she […]
CASE SERIES: Case 3 – 73-Year-Old Woman with Stage 4 Non-Hodgkin’s Lymphoma in Partial Remission
Case:A 73-year-old woman was diagnosed with Stage 4 non-Hodgkin’s lymphoma in 2019. She received: In 2020, she began: RESULTS: MY COMMENT: A terminal lymphoma case with skeletal spread showed measurable recovery using a non-toxic protocol. Even partial remission with improved function is a huge win for quality of life. Source: Chlorine dioxide solution in metastatic cancer: case seriesDOI: 10.22541/au.168503521.10282552/v3 For […]
CASE SERIES: Case 2 – 65-Year-Old Man with Metastatic Kidney Cancer in Complete Remission After Stopping Chemo
STORY:In 2018, a 65-year-old man with clear cell renal cell carcinoma underwent nephrectomy. Later developed lung metastases (4 mm & 5 mm nodules). He was treated with: However, he experienced serious side effects and discontinued treatment in 2020. Then started: RESULTS: MY TAKE:When standard treatments failed or caused toxicity, CDS and lifestyle change alone reversed lung metastases. This is […]